Related Experiment Video
Updated: May 29, 2026

Mouse Models Of Helicobacter Infection And Gastric Pathologies
Published on: October 18, 2018
Helicobacter pylori and autoimmune diseases
S Hasni1, A Ippolito, G G Illei
1National Institute of Arthritis and Musculoskeletal and Skin Diseases National Institutes of Health, Bethesda, MD 20892, USA. hasnisa@mail.nih.gov
Abstract:
Helicobacter pylori (H. pylori) is a widely prevalent microbe, with between 50 and 80% of the population infected worldwide. Clinically, infection with H. pylori is commonly associated with peptic ulcer disease, but many of those infected remain asymptomatic. H. pylori has evolved a number of means to affect the host immune response and has been implicated in many diseases mitigated by immune dysregulation, such as immune thrombocytopenic purpura (ITP), atrophic gastritis, and mucosa associated lymphoid tissue (MALT) lymphoma. Autoimmune diseases, such as systemic lupus erythematosus, rheumatoid arthritis, and Sjogren's syndrome, are the result of a dysregulated host immune system which targets otherwise healthy tissues. The exact etiology of autoimmune diseases is unclear, but it has long been suggested that exposure to certain environmental agents, such as viral and bacterial infection or chemical exposures, in genetically susceptible individuals may be the catalyst for the initiation of autoimmune processes. Because of its prevalence and ability to affect human immune function, many researchers have hypothesized that H. pylori might contribute to the development of autoimmune diseases. In this article, we review the available literature regarding the role of chronic H. pylori infection in various autoimmune disease states.
Insights
Helicobacter pylori (H. pylori) infection, common worldwide, may trigger autoimmune diseases by altering immune responses. This review examines the link between chronic H. pylori and conditions like lupus and rheumatoid arthritis.
Area of Science:
- Microbiology
- Immunology
- Gastroenterology
Background:
- Helicobacter pylori (H. pylori) is a prevalent bacterium affecting 50-80% of the global population.
- While often asymptomatic or linked to peptic ulcers, H. pylori influences host immune responses.
- Immune dysregulation associated with H. pylori contributes to conditions like ITP, atrophic gastritis, and MALT lymphoma.
Purpose of the Study:
- To review existing literature on the potential role of chronic H. pylori infection in the development of autoimmune diseases.
- To explore the hypothesis that H. pylori may initiate autoimmune processes in susceptible individuals.
Main Methods:
- Literature review of studies investigating the association between H. pylori infection and autoimmune diseases.
- Analysis of research on H. pylori's mechanisms of immune modulation.
- Synthesis of evidence linking H. pylori to immune-related conditions.
Main Results:
- H. pylori infection is linked to immune dysregulation, implicated in various non-autoimmune diseases.
- The bacterium's ability to affect host immunity supports hypotheses of its role in autoimmune disease initiation.
- Evidence suggests a potential connection between chronic H. pylori and autoimmune conditions.
Conclusions:
- Chronic H. pylori infection is a potential environmental factor contributing to the etiology of autoimmune diseases.
- Further research is warranted to elucidate the precise mechanisms by which H. pylori may trigger or exacerbate autoimmune conditions.
- Understanding this link could inform new diagnostic or therapeutic strategies for autoimmune disorders.
Related Concept Videos
Gastritis II: Pathophysiology
Gastritis-II: Pathophysiology
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune system...
Peptic Ulcer Disease II: Pathophysiology
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
